Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 7.80
-0.30 (-3.70%)
Jun 12, 2026, 9:30 AM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 19.02 million as of June 11, 2026. Its market cap has decreased by -86.13% in one year.
Market Cap
19.02M
Enterprise Value
3.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.80
Market Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 19.02M, a decrease of -90.38%. That is a compound annual growth rate of -37.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 19.02M | -79.50% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | 197.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 72.77M |
| Alzinova AB | 68.42M |
| Pila Pharma AB | 65.10M |
| Modus Therapeutics Holding AB | 56.44M |
| 2cureX AB | 56.15M |
| Fluicell AB | 46.02M |
| Magle Chemoswed Holding AB | 33.27M |
| Guard Therapeutics International AB | 28.19M |